Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:hospital
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:benefits |
patients with coronary artery disease
|
| gptkbp:clinical_trial |
coronary artery disease
conducted for efficacy |
| gptkbp:competes_with |
other drug-eluting stents
|
| gptkbp:developed_by |
gptkb:United_States
patient safety in mind |
| gptkbp:dividend_yield |
positive clinical outcomes
|
| gptkbp:features |
biodegradable polymer
|
| gptkbp:has |
radiopaque markers
|
| https://www.w3.org/2000/01/rdf-schema#label |
Celo Nova Stent
|
| gptkbp:indication |
percutaneous coronary intervention
|
| gptkbp:introduced |
2010s
|
| gptkbp:is |
a type of stent
|
| gptkbp:is_associated_with |
improved quality of life
|
| gptkbp:is_available_in |
various sizes
multiple lengths |
| gptkbp:is_compatible_with |
various delivery systems
|
| gptkbp:is_considered |
gptkb:municipality
|
| gptkbp:is_considered_as |
a safe option for patients
a breakthrough in stent technology |
| gptkbp:is_designed_for |
minimally invasive procedures
vascular interventions |
| gptkbp:is_designed_to |
enhance visibility during procedures
|
| gptkbp:is_evaluated_by |
gptkb:hospital
cost-effectiveness clinical studies |
| gptkbp:is_part_of |
interventional cardiology procedures
cardiovascular treatment options Celo Nova product line |
| gptkbp:is_promoted_by |
medical device companies
|
| gptkbp:is_recognized_by |
medical associations
|
| gptkbp:is_subject_to |
regulatory reviews
|
| gptkbp:is_supported_by |
research studies
clinical evidence |
| gptkbp:is_tested_for |
safety and efficacy
randomized trials |
| gptkbp:is_used_by |
interventional cardiologists
|
| gptkbp:is_used_in |
gptkb:various_countries
|
| gptkbp:is_used_to |
treat blockages
|
| gptkbp:is_utilized_in |
clinical practice
|
| gptkbp:manufacturer |
Celo Nova Bio Sciences
|
| gptkbp:meets |
gptkb:standard
|
| gptkbp:offers |
improved patient outcomes
|
| gptkbp:provides |
drug-eluting capabilities
long-term patency |
| gptkbp:reduces |
restenosis rates
complications during procedures |
| gptkbp:requires |
repeat interventions
|
| gptkbp:supports |
arterial walls
healing process |
| gptkbp:targets |
specific lesions
|
| gptkbp:used_in |
angioplasty procedures
|
| gptkbp:uses |
drug delivery technology
|
| gptkbp:utilizes |
advanced coating technology
|
| gptkbp:works_with |
imaging techniques
|
| gptkbp:bfsParent |
gptkb:Celo_Nova_Biosciences
|
| gptkbp:bfsLayer |
5
|